Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Diseases and Conditions Researched

Acute Episode of Overt Hepatic Encephalopathy; Hepatic Encephalopathy

What is the purpose of this trial?

The purpose of this study is to determine whether ornithine phenylacetate can speed recovery from an acute hepatic encephalopathy episode requiring hospitalization in cirrhotic patients.

Participation Guidelines

Age: 18 Years - 75 Years
Gender: Both

Click here for detailed participation information for this trial.

Sponsor: Ocera Therapeutics
Last Updated:
Study HIC#: 1402013361